药物对比
Canagliflozin vs Alogliptin
比较Canagliflozin与Alogliptin治疗2型糖尿病。了解SGLT2抑制剂与DPP-4抑制剂的机制、心血管获益、副作用，以及哪种可能更好。
此页面暂无可用的对比维度。
临床背景
This comparison arises when adding a second oral agent after metformin in type 2 diabetes patients with cardiovascular, renal, or heart-failure considerations.
结论
The better drug between Canagliflozin and Alogliptin is determined by individual comorbidities, treatment goals, and risk tolerance rather than a one-size-fits-all ranking.
全部药物对比